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redicting Ischemic
eart Disease in Women
he Value of Endothelial Function*
ill Q. Lian, MD, PHD, John F. Keaney, JR, MD
orcester, Massachusetts
ince the discovery in 1980 that acetylcholine elicits vaso-
ilation in an endothelium-dependent manner (1), it has
ecome evident that the endothelium plays a crucial role in
ascular homeostasis by regulating vasodilation, smooth
uscle cell proliferation and migration, platelet and leuko-
yte adhesion, and thrombosis. Endothelial dysfunction is
haracterized by the impairment of endothelium-dependent
asodilation due to reduced vasodilator bioactivity, particu-
arly nitric oxide (NO), and/or an increase in contracting
actors (2). In addition to its vasomotor manifestations,
ndothelial dysfunction extends to other endothelial prop-
rties, resulting in a proinflammatory and prothrombotic
ndothelial phenotype that promotes atherosclerosis, plaque
rogression, and the occurrence of clinical events.
See page 1688
Early studies of endothelial dysfunction focused on the
oronary circulation, demonstrating paradoxical vasocon-
triction to acetylcholine in patients with mild as well as
dvanced atherosclerosis (3). Subsequent studies showed
hat endothelial dysfunction is also present in both coronary
nd peripheral arteries in patients with risk factors, but
ithout angiographic or ultrasound evidence of structural
oronary artery disease (4,5). Indeed, almost all known
ardiovascular risk factors, including hypercholesterolemia,
ypertension, hyperglycemia, smoking, and aging, are asso-
iated with endothelial dysfunction (6–10). These findings
uggest that endothelial dysfunction contributes to the
evelopment of atherogenesis. There is also considerable
vidence that endothelial dysfunction contributes to clin-
cal events. Many studies in both the coronary and
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Divisions of General Internal Medicine and Cardiovascular Medicine,
epartment of Medicine, University of Massachusetts Medical School, Worcester,a
assachusetts. The work in Dr. Keaney’s laboratory is supported by National
nstitutes of Health grants AG027081, HL081587, and HL092122.eripheral circulation indicate that endothelial dysfunc-
ion is an independent predictor for the development of
ardiac events (11).
A major issue with assessment of endothelial function
s the choice of test. In clinical settings, endothelial
unction has been assessed primarily via vasomotion in
esponse to agonists (e.g., acetylcholine, flow) in the
oronary or peripheral circulation that induce endothelial
O release. Because coronary events are the principal
ource of morbidity and mortality from atherosclerosis,
ne might argue that the gold standard for endothelial
unction evaluations should be in the coronary circula-
ion. However, the invasive nature of intracoronary
tudies makes their broad application difficult. As a
onsequence, alternative methods that assess peripheral
ascular endothelial function have been developed.
mong these techniques, the high-resolution ultrasono-
raphic measurement of brachial artery flow-mediated
ilatation (FMD) has been used extensively (12). This
echnique involves induction of post-ischemic reactive
yperemia to elicit shear-induced endothelial NO release
nd vasodilation. This indirect measurement of endothe-
ial function is correlated with coronary endothelial
unction (13), consistent with the notion that precipitants
f endothelial dysfunction act systemically. Nevertheless,
MD use is limited to research settings owing to the
echnical demands required for consistent measurements.
Findings that abnormal patterns of pulse wave ampli-
ude were associated with atherosclerosis prompted new
nterest in developing simpler measurements of endo-
helial function (14). Accordingly, Kuvin et al. (15) used
specially designed finger plethysmograph for peripheral
rterial tonometry (PAT) to show that changes in pulse
ave amplitude during reactive hyperemia are correlated
ith brachial artery FMD. Subsequently, digital reactive
yperemia was found to be attenuated in patients with
oronary endothelial dysfunction (16). These findings
ere supported by observations in the Framingham Heart
tudy that digital reactive hyperemia-induced PAT
RH-PAT), as an index of vasodilator function, is cor-
elated with multiple traditional and metabolic cardio-
ascular risk factors (17). Collectively, these data suggest
hat RH-PAT could prove useful in the prediction of
oronary artery disease.
In this issue of the Journal, Matsuzawa et al. (18) have
emonstrated that impaired RH-PAT indices were pre-
ictive of ischemic heart disease in women. A similar
ecrement in RH-PAT indices was observed in both
bstructive (demonstrable coronary lesions) and nonob-
tructive coronary artery disease, defined as epicardial
oronary spasm, microvascular spasm, or microcirculatory
nsufficiency in the absence of significant epicardial ob-
truction. Consistent with previous studies, this study
lso found that the RH-PAT index is correlated with
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n acetylcholine infusion study.
As with any study claiming a new test for the predic-
ion of ischemic heart disease, one must ask whether
here is any additive information compared with previ-
usly published data. In this regard, Matsuzawa et al.
18) compared RH-PAT with the Reynolds Risk Score.
hey found that both the Reynolds Risk Score and the
H-PAT index predicted ischemic heart disease. How-
ver, only RH-PAT was significantly associated with
onobstructive coronary artery disease, and this index was
superior predictor of nonobstructive coronary artery
isease in women with angina-like symptoms lacking
ngiographic coronary artery disease. This is not surpris-
ng, as vasomotor dysfunction is a prominent source of
ymptoms in nonobstructive coronary artery disease, and
H-PAT is a measurement of vasomotor function.
The increase in digital pulse amplitude with reactive
yperemia is a complex response that reflects changes in
igital blood flow and microvessel dilation. Because endog-
nous NO is important for the control of resistance artery
one (19), it is not surprising that digital reactive hyperemia-
nduced pulse amplitude is mediated, in part, by NO.
owever, the NO-mediated component totals 60% of
igital artery dilation, whereas the remainder represents
ther vasodilator components (20). In contrast, brachial
rtery FMD is primarily a reflection of NO, as it is largely
locked by inhibitors of nitric oxide synthase (21). Thus it
s possible that RH-PAT may measure components of
asodilation not reflected in FMD, providing at least a
heoretical basis for a more comprehensive assessment of
ascular function. From a technical viewpoint, RH-PAT
lso has clear advantages over the established methods of
oronary angiography or ultrasound used to measure
ndothelial function. It is completely noninvasive, simple
o perform, and less prone to operator error and is thus
ore reproducible. These features hold promise for
llowing wider application of endothelial function testing
n clinical settings.
It is important to remember that the current study has
everal limitations. First, there were only 42 patients in this
tudy, significantly fewer than that in the Framingham
eynolds Risk Score study, with which the current study is
ntended to compare. Second, the study was conducted in a
ingle medical center. To validate the true value of RH-
AT in women, a second independent study applying the
ame criteria is needed. Most importantly, to establish the
sefulness of the test, prospective evaluation of future
ardiac events, rather than correlation with angiographic
ndings, will be crucial.
Thus, the study of Matsuzawa et al. (18) indicates that
H-PAT may serve as a simple measure to integrate risk
actor burden and to reflect overall conduit and microvas-
ular endothelial function. Consequently, RH-PAT has theotential for wide clinical application, should it be found to
redict risk of future cardiac events. Continued investiga-
ion will be needed to extend the findings of the current
tudy to more diverse populations and provide the necessary
inkage to clinical outcomes.
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